<?xml-stylesheet type='text/xsl' href='anzctrTransform.xsl'?>
<ANZCTR_Trial requestNumber="786">
  <stage>Registered</stage>
  <submitdate>23/09/2005</submitdate>
  <approvaldate>23/09/2005</approvaldate>
  <actrnumber>ACTRN12605000502639</actrnumber>
  <trial_identification>
    <studytitle>Ultrasound Study</studytitle>
    <scientifictitle>Ultrasound examination of Extensive Limb Swelling Reactions following DTPa or dTpa immunisation in preschool children</scientifictitle>
    <utrn />
    <trialacronym />
    <secondaryid>REC 1428/02/06</secondaryid>
  </trial_identification>
  <conditions>
    <healthcondition>Extensive Swelling Reactions following diphtheria-tetanus-acellular pertussis immunisation</healthcondition>
    <conditioncode>
      <conditioncode1>Respiratory</conditioncode1>
      <conditioncode2>Other respiratory disorders / diseases</conditioncode2>
    </conditioncode>
  </conditions>
  <interventions>
    <interventions>Descriptive study to assess extensive swelling reactions clinically and using ultrasound to identify tissue involvement.  Initial ultrasound examination and follow-up ultrasound 48 -96 hours later.</interventions>
    <comparator />
    <control />
    <interventioncode>None</interventioncode>
  </interventions>
  <outcomes>
    <primaryOutcome>
      <outcome>A description of the tissues involved and extent of tissue swelling following DTPa immunisation.</outcome>
      <timepoint>Ultrasound measure taken at 24 hours and 48-96 hours post first examination.</timepoint>
    </primaryOutcome>
    <secondaryOutcome>
      <outcome>To assess ultrasound as an aid to more accurate measurement of extensive limb swelling reactions.</outcome>
      <timepoint />
    </secondaryOutcome>
  </outcomes>
  <eligibility>
    <inclusivecriteria> Free of health problems;- extensive limb swelling reactions as defined by swelling &gt;50mms in size or 30% increase in upper limb swelling circumference follwoing DTPa or dTpa vaccination.</inclusivecriteria>
    <inclusiveminage>4</inclusiveminage>
    <inclusiveminagetype>Years</inclusiveminagetype>
    <inclusivemaxage>6</inclusivemaxage>
    <inclusivemaxagetype>Years</inclusivemaxagetype>
    <inclusivegender>Both males and females</inclusivegender>
    <healthyvolunteer>No</healthyvolunteer>
    <exclusivecriteria>Chronic administration of immunosuppresants or antiinflammatories 2 weeks prior to enrolment.</exclusivecriteria>
  </eligibility>
  <trial_design>
    <studytype>Observational</studytype>
    <purpose />
    <allocation />
    <concealment />
    <sequence />
    <masking />
    <assignment />
    <designfeatures />
    <endpoint />
    <statisticalmethods />
    <masking1 />
    <masking2 />
    <masking3 />
    <masking4 />
    <patientregistry />
    <followup />
    <followuptype />
    <purposeobs>Natural history</purposeobs>
    <duration>Cross-sectional</duration>
    <selection>Defined population</selection>
    <timing>Prospective</timing>
  </trial_design>
  <recruitment>
    <phase>Phase 4</phase>
    <anticipatedstartdate>1/03/2003</anticipatedstartdate>
    <actualstartdate />
    <anticipatedenddate />
    <actualenddate />
    <samplesize>12</samplesize>
    <actualsamplesize />
    <recruitmentstatus>Completed</recruitmentstatus>
    <recruitmentcountry>Australia</recruitmentcountry>
    <recruitmentstate />
  </recruitment>
  <sponsorship>
    <primarysponsortype>Hospital</primarysponsortype>
    <primarysponsorname>Women's and Children's Hospital (part of Children, Youth and Women's Health Service)</primarysponsorname>
    <primarysponsoraddress />
    <primarysponsorcountry>Australia</primarysponsorcountry>
    <fundingsource>
      <fundingtype>Self funded/Unfunded</fundingtype>
      <fundingname />
      <fundingaddress />
      <fundingcountry />
    </fundingsource>
    <secondarysponsor>
      <sponsortype>None</sponsortype>
      <sponsorname>Nil</sponsorname>
      <sponsoraddress />
      <sponsorcountry />
    </secondarysponsor>
  </sponsorship>
  <ethicsAndSummary>
    <summary />
    <trialwebsite />
    <publication />
    <ethicsreview>Approved</ethicsreview>
    <publicnotes />
    <ethicscommitee>
      <ethicname>Women's and Children's Hospital</ethicname>
      <ethicaddress />
      <ethicapprovaldate />
      <hrec />
      <ethicsubmitdate />
      <ethiccountry>Australia</ethiccountry>
    </ethicscommitee>
  </ethicsAndSummary>
  <attachment />
  <contacts>
    <contact>
      <title />
      <name>Dr Helen Marshall</name>
      <address>University Department of Paediatrics
Women's and Children's Hospital
72 King William Road
North Adelaide SA 5006</address>
      <phone>+61 8 81618115</phone>
      <fax>+61 8 81617031</fax>
      <email>helen.marshall@adelaide.edu.au</email>
      <country>Australia</country>
      <type>Scientific Queries</type>
    </contact>
    <contact>
      <title />
      <name>Dr Helen Marshall</name>
      <address>University Department of Paediatrics
Women's and Children's Hospital
72 King William Road
North Adelaide SA 5006</address>
      <phone>+61 8 81618115</phone>
      <fax>+61 8 81617031</fax>
      <email>helen.marshall@adelaide.edu.au</email>
      <country>Australia</country>
      <type>Public Queries</type>
    </contact>
    <contact>
      <title />
      <name />
      <address />
      <phone />
      <fax />
      <email />
      <country />
      <type>Updating Information</type>
    </contact>
    <contact>
      <title />
      <name />
      <address />
      <phone />
      <fax />
      <email />
      <country />
      <type>Principal Investigator</type>
    </contact>
  </contacts>
</ANZCTR_Trial>